US HB1362 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on February 26 2019 - 25% progression, died in committee
Action: 2019-02-27 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 26 2019 - 25% progression, died in committee
Action: 2019-02-27 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to allow, during a lapse in appropriations, acceptance of certain device submissions and registrations with the corresponding fees made available for obligation and expenditure for the process for the review of device applications, and for other purposes.
Title
Medical Innovation Never Stops Act of 2019
Sponsors
| Rep. Tom Emmer [R-MN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-02-27 | House | Referred to the Subcommittee on Health. |
| 2019-02-26 | House | Referred to the House Committee on Energy and Commerce. |
| 2019-02-26 | House | Introduced in House |
Subjects
Appropriations
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Executive agency funding and structure
Health
Licensing and registrations
User charges and fees
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Executive agency funding and structure
Health
Licensing and registrations
User charges and fees
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/1362/all-info |
| Text | https://www.congress.gov/116/bills/hr1362/BILLS-116hr1362ih.pdf |
